Teva, Intel to develop wearables to monitor Huntington's disease

(Reuters) - Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable device to monitor patients with Huntington's, a fatal degenerative disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news